Good Science Does
Not Sell Itself.
Approval is not adoption.
We build the positioning, the scientific narrative, and the stakeholder infrastructure that closes the gap.
Product Strategy
Scientific excellence has to earn its place in the market. A great clinical dataset is necessary, but not sufficient. What separates products that achieve clinical adoption from those that do not is almost always strategic: the positioning, the scientific narrative, and the stakeholder infrastructure built around them.
Scientific Positioning & Launch Strategy
Define your product’s scientific value proposition, differentiate it in the competitive evidence landscape, and build the Medical Affairs strategy to carry it into clinical practice.
Deliverables:
Scientific platform, Competitive landscape, KOL strategy, MA launch plan.
Ideal For:
- New products approaching launch
- Mature products requiring revitalization.
Medical Advisory Services
An ongoing strategic partnership where Gabriel & Co serves as an embedded Medical Affairs thought partner, continuously aligning evidence, stakeholder engagement, and scientific communication strategy.
Engagement:
Monthly retainer with defined strategic deliverables.
Ideal For:
- Organizations needing MA strategic guidance without a full-time hire.
- Indian biotech and specialty pharma at commercial stage.
Stakeholder Engagement & KOL Strategy
Identify, map, and build authentic scientific relationships with KOLs, Therapy Area Leaders, and clinical stakeholders.
Outcome:
Authentic scientific partnerships aligned to your evidence and publication strategy.
Ideal For:
- Specialist therapy areas where HCP scientific credibility drives adoption and guideline influence.